Metabolic alterations associated with the antidiabetic effect of beta 3-adrenergic receptor agonists in obese mice
Authors:
- 1 April 1995
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 268 (4) , E678-E684
Abstract
Treatment of obese (ob/ob) mice with the beta 3-adrenergic receptor (beta 3-AR) agonist BRL-35135 (1 mg.kg body wt-1.day-1 for 20 days) normalized plasma glucose levels and significantly decreased plasma insulin and nonesterified fatty acid levels. The time frame for the hypoglycemic effect, which reached a maximum after 10 days of treatment, paralleled an increase in brown adipose tissue DNA and protein content. The basal level of mRNA for the beta 3-AR and mitochondrial uncoupling protein was found to be markedly decreased in the ob/ob animals relative to the lean group. Chronic treatment of ob/ob mice for 20 days resulted in a twofold increase in beta 3-AR mRNA and a fivefold increase in uncoupling protein mRNA in brown adipose tissue relative to the placebo group. These findings indicate that chronic treatment of ob/ob animals with a beta 3-AR agonist results in proliferation of brown adipose tissue, with an upregulation of the beta 3-AR, which is associated with a decrease in plasma glucose, insulin, and nonesterified fatty acid levels.Keywords
This publication has 27 references indexed in Scilit:
- The promoter and intron/exon structure of the human and mouse β3‐adrenergic‐receptor genesEuropean Journal of Biochemistry, 1993
- Tissue distribution of beta 3-adrenergic receptor mRNA in man.Journal of Clinical Investigation, 1993
- Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent .beta.-adrenergic agonist virtually specific for .beta.3 receptors. A promising antidiabetic and antiobesity agentJournal of Medicinal Chemistry, 1992
- Molecular Characterization of the Human β 3 -Adrenergic ReceptorScience, 1989
- Does brown adipose tissue have a role to play in glucose homeostasis?Proceedings of the Nutrition Society, 1989
- Brown adipose tissue thermogenesis and obesityProgress in Lipid Research, 1989
- Substrate supply for thermogenesis induced by the β-adrenoceptor agonist BRL 26830ACanadian Journal of Physiology and Pharmacology, 1987
- Brown adipose tissue is a major site of glucose utilisation in C57B16obob mice treated with a thermogenic β-adrenoceptor agonistBiochemical and Biophysical Research Communications, 1985
- Measurement by radioimmunoassay of the mitochondrial uncoupling protein from brown adipose tissue of obese (ob/ob) mice and Zucker (fa/fa) rats at different agesFEBS Letters, 1985
- THE GLUCOSE FATTY-ACID CYCLE ITS ROLE IN INSULIN SENSITIVITY AND THE METABOLIC DISTURBANCES OF DIABETES MELLITUSThe Lancet, 1963